GOP strategist Matt Wylie looks into the future after an undeniably strong few weeks by President Donald Trump and wonders ...

"Baxdrostat BaxHTN Phase III trials on patients with uncontrolled or treatment-resistant hypertension demonstrated a statistically significant and clinically meaningful reduction in mean-seated ...